North America genital herpes treatment market is projected to grow by 3.9% annually in the forecast period and reach $1,650.9 million by 2032, driven by the rising prevalence of sexually transmitted diseases, changing socio-cultural openness, increasing awareness about HSV infection and its symptoms, improved access to antiviral medications, and the government supports.
Highlighted with 25 tables and 44 figures, this 107-page report "North America Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity" is based on comprehensive research of the entire North America genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America genital herpes treatment market in every aspect of the classification from perspectives Virus, Drug Type, Route of Administration, Patient Gender, Distribution Channel, and Country.
Based on Virus Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• HSV-1
• HSV-2
Based on Drug Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Acyclovir
• Valacyclovir
• Famciclovir
• Other Drugs
By Route of Administration, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Oral
• Topical
• Injection
By Patient Gender, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Female
• Male
By Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Drug Stores
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Virus Type, Drug Type and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter's Fiver Forces Analysis 36
3 Segmentation of North America Market by Virus Type 40
3.1 Market Overview by Virus Type 40
3.2 HSV-1 42
3.3 HSV-2 43
4 Segmentation of North America Market by Drug Type 44
4.1 Market Overview by Drug Type 44
4.2 Acyclovir 47
4.3 Valacyclovir 48
4.4 Famciclovir 49
4.5 Other Drugs 50
5 Segmentation of North America Market by Route of Administration 52
5.1 Market Overview by Route of Administration 52
5.2 Oral 54
5.3 Topical 55
5.4 Injection 56
6 Segmentation of North America Market by Patient Gender 57
6.1 Market Overview by Patient Gender 57
6.2 Female 59
6.3 Male 60
7 Segmentation of North America Market by Distribution Channel 61
7.1 Market Overview by Distribution Channel 61
7.2 Retail Pharmacies 63
7.3 Hospital Pharmacies 64
7.4 Online Pharmacies 65
7.5 Drug Stores 66
8 North America Market 2022-2032 by Country 67
8.1 Overview of North America Market 67
8.2 U.S. 70
8.3 Canada 75
8.4 Mexico 77
9 Competitive Landscape 79
9.1 Overview of Key Vendors 79
9.2 New Product Launch, Partnership, Investment, and M&A 82
9.3 Company Profiles 83
Abbott 83
ADLEY FORMULATIONS 85
Aurobindo Pharma Ltd. 86
Avet Pharmaceuticals Inc. 87
Bausch Health Companies 88
Centurion Remedies 89
Cipla Ltd. 90
Eli Lilly & Company 91
Finecure Pharmaceuticals 92
GlaxoSmithKline Plc 93
Glenmark Pharmaceuticals 94
Macleods Pharmaceuticals 95
Medico Remedies 96
Merck & Co., Inc. 97
Novartis AG 98
Pfizer 99
Reddy's Laboratories 100
Sanofi SA 101
Teva Pharmaceutical Industries Ltd. 102
Torrent Pharma 103
Viatris Inc. 104
Zeelab Pharmacy 105
Zydus Pharmaceuticals, Inc. 106
RELATED REPORTS 107
Market Overview
The North America Banking as a Service (BaaS) Market is poised for significant growth from 2024 to 2034, driven by the digital transformation of financial services, the increasing demand for seamless integration of banking solutions, and the expansion of fintech partners...
Market Overview
The North America Perfume Packaging Market is set to experience robust growth from 2024 to 2034, driven by rising consumer preferences for premium fragrances, innovations in sustainable packaging, and the growing popularity of e-commerce. The market size is projected to ...
Market Overview
The North America Alternate Marine Power Market is poised for significant growth from 2024 to 2034, driven by stringent environmental regulations, rising concerns about marine pollution, and advancements in clean energy technologies. The market size is projected to expan...
Market Overview
The North America Bio Vanillin Market is projected to experience robust growth from 2024 to 2034, driven by the rising demand for natural and sustainable flavoring agents, increasing consumer preference for clean-label products, and expanding applications across various ...
Market Overview
The North America AI-Enabled Biometric Market is projected to experience substantial growth from 2024 to 2034, driven by the increasing demand for advanced, secure, and convenient identity verification solutions across various sectors. With rising adoption in areas such ...
Market Overview
The North America Commercial Vehicle Telematics Market is poised for significant growth from 2024 to 2034, driven by the rising demand for real-time fleet monitoring, enhanced vehicle safety, and regulatory mandates for fleet management. The market is expected to expand ...
Market Overview
The North America Passive Optical Network (PON) Market is set to experience substantial growth from 2024 to 2034, fueled by increasing investments in fiber-optic infrastructure and growing demand for high-speed, reliable internet connectivity. Projected to reach USD XXX....
Market Overview
The Asia Pacific Safety Valves Market is expected to witness substantial growth from 2024 to 2034, driven by increasing industrial activities and the rising demand for enhanced safety standards across key sectors. The market is projected to reach USD XX.XX billion by 203...
Market Overview
The Europe Safety Valves Market is projected to witness steady growth from 2024 to 2034, driven by rising demand across critical industries such as oil and gas, energy and power, and water treatment. With increased focus on safety and regulatory compliance, the market is...
Market Overview
The North America Safety Valves Market is anticipated to grow significantly from 2024 to 2034, driven by increasing demand across key industries such as oil & gas, energy & power, and water & wastewater treatment. Projected to reach USD XXX.XX million by 2034 from USD XX...